刊名:Graefe's Archive for Clinical and Experimental Ophthalmology
出版年:2016
出版时间:January 2016
年:2016
卷:254
期:1
页码:43-51
全文大小:1,336 KB
参考文献:1.Irvine SR (1953) A newly defined vitreous syndrome following cataract surgery. Am J Ophthalmol 36:599–619PubMed CrossRef 2.Irvine AR (1976) Cystoid maculopathy. Surv Ophthalmol 21:1–17PubMed CrossRef 3.Gass JD, Norton EW (1966) Fluorescein studies of patients with macular edema and papilledema following cataract extraction. Trans Am Ophthalmol Soc 64:232–249PubMed PubMedCentral 4.Gass JD, Norton EW (1966) Cystoid macular edema and papilledema following cataract extraction. A fluorescein fundoscopic and angiographic study. Arch Ophthalmol 76:646–661PubMed CrossRef 5.Arcieri ES, Santana A, Rocha FN, Guapo GL, Costa VP (2005) Blood-aqueous barrier changes after the use of prostaglandin analogues in patients with pseudophakia and aphakia: a 6-month randomized trial. Arch Ophthalmol 123:186–192PubMed CrossRef 6.Henderson BA, Kim JY, Ament CS, Ferrufino-Ponce ZK, Grabowska A, Cremers SL (2007) Clinical pseudophakic cystoid macular edema. Risk factors for development and duration after treatment. J Cataract Refract Surg 33:1550–1558PubMed CrossRef 7.Perente I, Utine CA, Ozturker C, Cakir M, Kaya V, Eren H, Kapran Z, Yilmaz OF (2007) Evaluation of macular changes after uncomplicated phacoemulsification surgery by optical coherence tomography. Curr Eye Res 32:241–247PubMed CrossRef 8.Fung WE (1984) The national, prospective, randomized vitrectomy study for chronic aphakic cystoid macular edema. Progress report and comparison between the control and nonrandomized groups. Surv Ophthalmol 28(Suppl):569–575PubMed CrossRef 9.Gass JD, Anderson DR, Davis EB (1985) A clinical, fluorescein angiographic, and electron microscopic correlation of cystoid macular edema. Am J Ophthalmol 100:82–86PubMed CrossRef 10.Newsom WA, Hood CI, Horwitz JA, Fine SL, Sewell JH (1972) Cystoid macular edema: histopathologic and angiographic correlations. A clinicopathologic case report. Trans Am Acad Ophthalmol Otolaryngol 76:1005–1009PubMed 11.Sears ML (1984) Aphakic cystoid macular edema. The pharmacology of ocular trauma. Surv Ophthalmol 28(Suppl):525–534PubMed CrossRef 12.Wright PL, Wilkinson CP, Balyeat HD, Popham J, Reinke M (1988) Angiographic cystoid macular edema after posterior chamber lens implantation. Arch Ophthalmol 106:740–744PubMed CrossRef 13.Albert DW, Wade EC, Parrish RK 2nd, Flynn HW Jr, Slomovic AR, Tanenbaum M, Blodi C (1990) A prospective study of angiographic cystoid macular edema one year after Nd: YAG posterior capsulotomy. Ann Ophthalmol 22:139–143PubMed 14.Ozyol E, Ozyol P, Doganay Erdogan B, Onen M (2014) The role of anterior hyaloid face integrity on retinal complications during Nd: YAG laser capsulotomy. Graefes Arch Clin Exp Ophthalmol 252:71–75PubMed CrossRef 15.Yannuzzi LA, Landau AN, Turtz AI (1981) Incidence of aphakic cystoid macular edema with the use of topical indomethacin. Ophthalmology 88:947–954PubMed CrossRef 16.Wittpenn JR, Silverstein S, Heier J, Kenyon KR, Hunkeler JD, Earl M, Acular LSfCMESG (2008) A randomized, masked comparison of topical ketorolac 0.4% plus steroid vs steroid alone in low-risk cataract surgery patients. Am J Ophthalmol 146:554–560PubMed CrossRef 17.Warren KA, Bahrani H, Fox JE (2010) NSAIDs in combination therapy for the treatment of chronic pseudophakic cystoid macular edema. Retina 30:260–266PubMed CrossRef 18.Yilmaz T, Cordero-Coma M, Gallagher MJ (2012) Ketorolac therapy for the prevention of acute pseudophakic cystoid macular edema: a systematic review. Eye (Lond) 26:252–258CrossRef 19.Sebag J, Balazs EA (1984) Pathogenesis of cystoid macular edema: an anatomic consideration of vitreoretinal adhesions. Surv Ophthalmol 28(Suppl):493–498PubMed CrossRef 20.Schepens CL, Avila MP, Jalkh AE, Trempe CL (1984) Role of the vitreous in cystoid macular edema. Surv Ophthalmol 28(Suppl):499–504PubMed CrossRef 21.Fung WE (1985) Vitrectomy for chronic aphakic cystoid macular edema. Results of a national, collaborative, prospective, randomized investigation. Ophthalmology 92:1102–1111PubMed CrossRef 22.Patel A, de Bustros S, Michels RG (1985) Pars plana vitrectomy for aphakic cystoid macular edema. Retina 5:11–15PubMed CrossRef 23.Peyman GA, Canakis C, Livir-Rallatos C, Conway MD (2002) The effect of internal limiting membrane peeling on chronic recalcitrant pseudophakic cystoid macular edema: a report of two cases. Am J Ophthalmol 133:571–572PubMed CrossRef 24.Sevim MS, Sanisoglu H, Turkyilmaz K (2012) Intravitreal triamcinolone acetonide versus pars plana vitrectomy for pseudophakic cystoid macular edema. Curr Eye Res 37:1165–1170PubMed CrossRef 25.Harbour JW, Smiddy WE, Rubsamen PE, Murray TG, Davis JL, Flynn HW Jr (1995) Pars plana vitrectomy for chronic pseudophakic cystoid macular edema. Am J Ophthalmol 120:302–307PubMed CrossRef 26.Spitzer MS, Ziemssen F, Yoeruek E, Petermeier K, Aisenbrey S, Szurman P (2008) Efficacy of intravitreal bevacizumab in treating postoperative pseudophakic cystoid macular edema. J Cataract Refract Surg 34:70–75PubMed CrossRef 27.Spitzer MS, Szurman P, Bartz-Schmidt KU (2008) Intravitreal bevacizumab in postoperative pseudophakic cystoid macular edema: does it really work? J Cataract Refract Surg 34:880, author reply 880-881PubMed CrossRef 28.Arevalo JF, Maia M, Garcia-Amaris RA, Roca JA, Sanchez JG, Berrocal MH, Wu L (2009) Intravitreal bevacizumab for refractory pseudophakic cystoid macular edema: the Pan-American Collaborative Retina Study Group results. Ophthalmology 116:1481–1487, 1487 e1481PubMed CrossRef 29.Ghasemi Falavarjani K, Parvaresh MM, Modarres M, Hashemi M, Samiy N (2012) Intravitreal bevacizumab for pseudophakic cystoid macular edema; a systematic review. J Ophthal Vis Res 7:235–239 30.Yanoff M, Fine BS, Brucker AJ, Eagle RC Jr (1984) Pathology of human cystoid macular edema. Surv Ophthalmol 28(Suppl):505–511PubMed CrossRef 31.Wolter JR (1981) The histopathology of cystoid macular edema. Graefes Arch Clin Exp Ophthalmol 216:85–101CrossRef 32.Markomichelakis NN, Halkiadakis I, Pantelia E, Peponis V, Patelis A, Theodossiadis P, Theodossiadis G (2004) Patterns of macular edema in patients with uveitis: qualitative and quantitative assessment using optical coherence tomography. Ophthalmology 111:946–953. doi:10.1016/j.ophtha.2003.08.037 PubMed CrossRef 33.Tran TH, de Smet MD, Bodaghi B, Fardeau C, Cassoux N, Lehoang P (2008) Uveitic macular oedema: correlation between optical coherence tomography patterns with visual acuity and fluorescein angiography. Br J Ophthalmol 92:922–927PubMed CrossRef 34.Munk MR, Bolz M, Huf W, Sulzbacher F, Roberts P, Simader C, Ruckert R, Kiss CG (2013) Morphologic and functional evaluations during development, resolution, and relapse of uveitis-associated cystoid macular edema. Retina 33:1673–1683PubMed CrossRef 35.Gartner S (1964) Optic neuritis and macular edema following cataract extraction. Eye Ear Nose Throat Mon 43:45–49PubMed 36.Brar M, Yuson R, Kozak I, Mojana F, Cheng L, Bartsch DU, Oster SF, Freeman WR (2010) Correlation between morphologic features on spectral-domain optical coherence tomography and angiographic leakage patterns in macular edema. Retina 30:383–389PubMed PubMedCentral CrossRef 37.Liu H, Demetriades AM, Xiao WH, Campochiaro PA, Vinores SA (2004) Mouse model of post-surgical breakdown of the blood-retinal barrier. Curr Eye Res 28:421–426PubMed CrossRef 38.Sigler EJ, Randolph JC, Charles S (2013) Delayed onset inner nuclear layer cystic changes following internal limiting membrane removal for epimacular membrane. Graefes Arch Clin Exp Ophthalmol 251:1679–1685PubMed CrossRef 39.Gelfand JM, Nolan R, Schwartz DM, Graves J, Green AJ (2012) Microcystic macular oedema in multiple sclerosis is associated with disease severity. Brain 135:1786–1793PubMed PubMedCentral CrossRef 40.Saidha S, Sotirchos ES, Ibrahim MA, Crainiceanu CM, Gelfand JM, Sepah YJ, Ratchford JN, Oh J, Seigo MA, Newsome SD, Balcer LJ, Frohman EM, Green AJ, Nguyen QD, Calabresi PA (2012) Microcystic macular oedema, thickness of the inner nuclear layer of the retina, and disease characteristics in multiple sclerosis: a retrospective study. Lancet Neurol 11:963–972PubMed PubMedCentral CrossRef 41.Abegg M, Dysli M, Wolf S, Kowal J, Dufour P, Zinkernagel M (2014) Microcystic macular edema: retrograde maculopathy caused by optic neuropathy. Ophthalmology 121:142–149PubMed CrossRef 42.Abegg M, Zinkernagel M, Wolf S (2012) Microcystic macular degeneration from optic neuropathy. Brain 135:e225PubMed CrossRef 43.Wolff B, Basdekidou C, Vasseur V, Mauget-Faysse M, Sahel JA, Vignal C (2013) Retinal inner nuclear layer microcystic changes in optic nerve atrophy: a novel spectral-domain OCT finding. Retina 33:2133–2138PubMed CrossRef
作者单位:Eric J. Sigler (1) John C. Randolph (2) Daniel F. Kiernan (1)
1. Division of Retina and Vitreous, Ophthalmic Consultants of Long Island, 2000 North Village Avenue, suite 402, Rockville Centre, NY, 11570, USA 2. Division of Retina and Vitreous, Vistar Eye Center, Roanoke, VA, USA
刊物类别:Medicine
刊物主题:Medicine & Public Health Ophthalmology
出版者:Springer Berlin / Heidelberg
ISSN:1435-702X
文摘
Purpose To describe the relationship between pseudophakic cystoid macular edema (CME) progression and retinal structural changes observed by spectral-domain optical coherence tomography (SD-OCT) and fluorescein angiography.